Decreased expressions of thrombospondin 2 in cyclosporin A-induced gingival overgrowth

Journal of Periodontal Research

Volumn 39, Issue 2, 2004, Pages 93-100

  Jeong, Tae Koh ^a   Ok, Joon Kim ^a   Young, Seob Park ^a   Sun, Hun Kim ^a   Won, Jae Kim ^a   Hyun, Ju Chung ^a   Shee, Eun Lee ^a   Byung, Chul Jeong ^a   Ji, Yeon Jung ^a   Kyung, Keun Kim ^a  

^a Chonnam National University   (South Korea)

Author keywords

Angiogenesis; Cyclosporin; Gingival overgrowth; Thrombospondin

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOSTATIN; BASIC FIBROBLAST GROWTH FACTOR; BRAIN PROTEIN; BRAIN SPECIFIC ANGIOGENESIS INHIBITOR 1; BRAIN SPECIFIC ANGIOGENESIS INHIBITOR 2; CYCLOSPORIN A; ENDOTHELIAL CELL GROWTH FACTOR; THROMBOSPONDIN 2; UNCLASSIFIED DRUG; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; CELL ADHESION MOLECULE; CYCLOSPORIN; FIBROBLAST GROWTH FACTOR 2; HIAF 1 PROTEIN, HUMAN; HIAF-1 PROTEIN, HUMAN; PROTEIN; THROMBOSPONDIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBROBLAST; FIBROBLAST CULTURE; GENE; GINGIVA OVERGROWTH; GINGIVECTOMY; HUMAN; HUMAN CELL; HUMAN TISSUE; INJECTION; INTERMETHOD COMPARISON; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOOTH CROWN; ANIMAL; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GINGIVA; METABOLISM; SPRAGUE DAWLEY RAT; TIME; WESTERN BLOTTING;

ANGIOGENESIS INHIBITORS; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; GINGIVA; GINGIVAL OVERGROWTH; HUMANS; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOSPONDINS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1842863013     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2004.00709.x     Document Type: Article

References (37)

1. Seymour RA, Jacobs DJ. Cyclosporin and the gingival tissues. J Clin Periodontol 1992;19:1-11.
2. Schreiber SL. Immunophilin-sensitive protein phosphatase action in cell signaling pathways. Cell 1992;70:365-368.
3. Mascarell L, Truffa-Bachi P. Cyclosporin A therapy differently affects immunological-relevant gene expression following immunization. Immunol Lett 2002;84:137-143.
4. Atkinson K, Biggs J, Darveniza P, Boland J, Concannon A, Dodds A. Cyclosporin-associated central nervous system toxicity after allogeneic bone marrow transplantation. Transplantation 1984;38:34-37.
5. Bartold PM. Cyclosporine and gingival overgrowth. J Oral Pathol 1987;16:463-468.
6. Tyldesley WR, Rotter E. Gingival hyperplasia induced by cyclosporin-A. Br Dent J 1984;157:305-309.
7. Rostock MH, Fry HR, Turner JE. Severe gingival overgrowth associated with cyclosporine therapy. J Periodontol 1986;57:294-299.
8. Friskopp J, Klintmalm G. Gingival enlargement. A comparison between cyclosporine and azathioprine treated renal allograft recipients. Swed Dent J 1986; 10:85-92.
9. Ayanoglou CM, Lesty C. Cyclosporin A-induced gingival overgrowth in the rat: a histological, ultrastructural and histomorphometric evaluation. J Periodont Res 1999;34:7-15.
10. Wondimu B, Reinholt FP, Modeer T. Stereologic study of Cyclosporin A-induced gingival overgrowth in renal transplant patients. Eur J Oral Sci 1995;103:199-206.
11. Kataoka M, Shimizu Y, Kunikiyo K et al. Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth. J Cell Physiol 2000;182:351-358.
12. Bolzani G, Della Coletta R, Martelli Junior H, Martelli Junior H, Graner E. Cyclosporin A inhibits production and activity of matrix metalloproteinases by gingival fibroblasts. J Periodont Res 2000;35:51-58.
13. Kalluri R, Sukhatme VP. Fibrosis and angiogenesis. Curr Opin Nephrol Hypertens 2000;9:413-418.
14. Ribatti D, Vacca A, Cantatore FP et al. An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis. Inflamm Res 2000;49:418-423.
15. Esposito C, Fornoni A, Cornacchia F et al. Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures. Kidney Int 2000;58:123-130.
16. Wassef R, Cohen Z, Nordgren S, Langer B. Cyclosporine absorption in intestinal transplantation. Transplantation 1985;39:496-499.
17. 3 integrin, osteopontin, and thrombin. Am J Pathol 1996;149:293-305.
18. 1 integrins. Proc Natl Acad Sci USA 1997;94:13612-13617.
19. Connolly DT, Heuvelman DM, Nelson R et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989;84:1470-1478.
20. Detmar M. The role of VEGF and thrombospondins in skin angiogenesis. J Dermatol Sci 2000;24:S78-S84.
21. Yuan K, Jin YT, Lin MT. The detection and comparison of angiogenesis-associated factors in pyogenic granuloma by immunohistochemistry. J Periodontol 2000;71:701-709.
22. Shihab FS, Bennett WM, Yi H, Andoh TF. Expression of vascular endothelial growth factor and its receptors Flt-1 and KDR/Flk-1 in chronic cyclosporine nephrotoxicity. Transplantation 2001;72:164-168.
23. Hernandez GL, Volpert OV, Iniguez MA et al. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med 2001;193:607-620.
24. Saito K, Mori S, Iwakura M, Sakamoto S. Immunohistochemical localization of transforming growth factor β, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin. J Periodont Res 1996;31:545-555.
25. Sasaki T, Maita E. Increased bFGF level in the serum of patients with phenytoin-induced gingival overgrowth. J Clin Periodontol 1998;25:42-47.
26. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 1993;122:497-511.
27. Grossfeld GD, Ginsberg DA, Stein JP et al. Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 1997;89:219-227.
28. Tokunaga T, Oshika Y, Abe Y et al. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 1998;77:998-1002.
29. Tokunaga T, Nakamura M, Oshika Y et al. Alterations in tumour suppressor gene p53 correlate with inhibition of thrombospondin-1 gene expression in colon cancer cells. Virchows Arch 1998;433:415-418.
30. Oshika Y, Masuda K, Tokunaga T et al. Thrombospondin 2 gene expression is correlated with decreased vascularity in non-small cell lung cancer. Clin Cancer Res 1998;4:1785-1788.
31. Streit M, Riccardi L, Velasco P et al. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci USA 1999;96: 14888-14893.
32. Alzuherri H, Chang KC. Calcineurin activates NF-κB in skeletal muscle C2C12 cells. Cell Signal 2003;15:471-478.
33. Jorgensen KA, Koefoed-Nielsen PB, Karamperis N. Calcineurin phosphatase activity and immunosuppression. A review on the role of calcineurin phosphatase activity and the immunosuppressive effect of cyclosporin A and tacrolimus. Scand J Immunol 2003;57:93-98.
34. Aoki Y, Kao PN. Cyclosporin A-sensitive calcium signaling represses NFkappaB activation in human bronchial epithelial cells and enhances NFkappaB activation in Jurkat T-cells. Biochem Biophys Res Commun 1997;234:424-431.
35. Nishimori H, Shiratsuchi T, Urano T et al. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 1997;15:2145-2150.
36. Koh JT, Lee ZH, Ahn KY et al. Characterization of mouse brain-specific angiogenesis inhibitor 1 (BAI1) and phytanoyl-CoA alpha-hydroxylase-associated protein 1, a novel BAI1-binding protein. Brain Res Mol Brain Res 2001;87:223-237.
37. Fukushima Y, Oshika Y, Tsuchida T et al. Brain-specific angiogenesis inhibitor 1 expression is inversely correlated with vascularity and distant metastasis of colorectal cancer. Int J Oncol 1998;13:967-970.